Insulet
PODD
#1369
Rank
$11.13 B
Marketcap
$159.49
Share price
-2.67%
Change (1 day)
-38.86%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2023 (TTM): $84.5 M

According to Insulet's latest financial reports the company's current earnings (TTM) are $84.5 M. In 2022 the company made an earning of $36.5 M a decrease over its 2021 earnings that were of $81.7 M.The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2023

Annual earnings

Year Earnings Change
2023 (TTM)$84.5 M131.51%
2022$36.5 M-55.32%
2021$81.7 M49.09%
2020$54.8 M20.77%
2019$45.37 M39.08%
2018$32.62 M-569.22%
2017-$6.96 M-44.06%
2016-$12.43 M-79.51%
2015-$60.65 M90.69%
2014-$31.81 M9.27%
2013-$29.11 M-18.96%
2012-$35.92 M
2010-$34.21 M-42.38%
2009-$59.36 M-33.56%
2008-$89.35 M65.93%
2007-$53.85 M229.68%
2006-$16.34 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$24.83 B 29,292.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.27 B 7,327.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.13 B 7,162.72%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$7.28 B 8,515.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.23 B-362.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.85 M-89.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.52 B 518.93%๐Ÿ‡บ๐Ÿ‡ธ USA